Hexagon Nutrition Limited
Minimum investment
Bidding date
05 Jun - 09 Jun 2026
Price range
₹42 - ₹45
Minimum quantity
333
Minimum investment
₹14,985
Issue size
₹139 Cr.
IPO doc (link)
RHP docs
Listing exchange
NSE/BSE
Total Issue Size:
₹139 Crore
Fresh Issue: 0% (₹0 Cr)
OFS: 100% (₹139 Cr)
Fresh Issue – ₹0 Crore
Offer for Sale – ₹139 Crore
Before Issue: 89.41%
After Issue: 64.29%
Lock-in / Stabilization | Timeline |
|---|---|
Minimum Promoter Contribution | 18 Months |
Promoter Holding Above 20% Post Issue Capital | 6 Months |
Anchor Investor Shares (50%) | 90 Days |
Remaining Anchor Investor Shares (50%) | 30 Days |
Note: Retail IPO investors have no lock-in and can sell shares from the listing day.
Hexagon Nutrition Ltd. is a research-oriented nutrition and healthcare company incorporated in 1993, specializing in micronutrient premixes, clinical nutrition, wellness supplements, therapeutic products, and ready-to-use nutrition foods. Over the years, the company has built a strong presence in both domestic and international markets through its diversified product portfolio and innovation-focused business model. Hexagon Nutrition operates manufacturing facilities in Nasik, Chennai, Thoothukudi, and an overseas unit in Uzbekistan, helping the company efficiently serve global demand. Its products are distributed through pharmacies, hospitals, e-commerce platforms, and its own nutrition brands including Pentasure, Obesigo, Pediagold, and Nutrone. With exports to more than 75 countries and dedicated in-house R&D centers, the company continues to focus on expanding its footprint in the fast-growing nutrition and wellness industry.
Strong Brand Presence: Hexagon Nutrition Ltd. has built a recognized presence in the nutrition and wellness industry through its clinical nutrition, wellness supplements, and micronutrient products across domestic and international markets.
Global Export Network: The company exports its products to more than 75 countries across Asia, Africa, Europe, and South America, helping diversify revenue sources and strengthen international business opportunities.
Diversified Business Model: Hexagon Nutrition operates across multiple categories including B2B premixes, B2C wellness products, and ESG-focused nutrition solutions, reducing dependence on a single business segment.
In-House Research & Development: The company has dedicated R&D facilities in Nasik and Chennai, supporting product innovation, quality improvement, and development of specialized nutrition solutions.
Improving Financial Performance: The company has reported consistent growth in profitability and margins over recent years, supported by rising revenue, improving PAT margins, and healthy EBITDA performance.
Entirely an OFS Issue: The IPO is completely an Offer for Sale (OFS), which means the company will not receive fresh capital from the public issue for future expansion or business growth.
Raw Material Price Volatility: The company’s profitability may be affected by fluctuations in raw material prices and supply chain disruptions, which can impact production costs and margins.
Highly Competitive Industry: The nutrition and healthcare sector is highly competitive with the presence of several established domestic and international players.
Regulatory & Compliance Risk: Since the company operates globally, it must comply with multiple regulatory standards and approvals across different countries, which may impact operations if regulations change.
Revenue Concentration Risk: A significant portion of revenue may depend on specific nutrition categories and products, creating concentration risk if demand slows in those segments.
275.57 Cr.
Dec'25
27.03 Cr.
Dec'25
37.55 Cr.
Dec'25
57 investors voted
Active IPOs | |
|---|---|
Company name | Bid starts |
Cmr Green Technologies | 03-06-2026 |
Hexagon Nutrition | 05-06-2026 |
